Article Information
History
- April 3, 2024.
Article Versions
- Version 1 (January 17, 2024 - 07:15).
- Version 2 (January 20, 2024 - 04:20).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Muktar B. Ahmed, PhD1,
- Anwar Mulugeta, PhD2,3,
- Niran Okewole, PhD4,
- Klaus Oliver Schubert, MD, PhD1,5,6,
- Scott R. Clark, MBBS, PhD1,5,6,
- Conrad O. Iyegbe, PhD7 and
- Azmeraw T. Amare, PhD1,*
- 1Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia
- 2Australian Centre for Precision Health, University of South Australia, Adelaide, SA, Australia
- 3UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia
- 4Neuropsychiatric Hospital Aro, Abeokuta, Nigeria
- 5Northern Adelaide Local Health Network, Mental Health Services, Australia
- 6Headspace Adelaide Early Psychosis, Sonder, Adelaide, Australia
- 7Department of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai, New York, USA
- ↵*Correspondence to:
Azmeraw T. Amare, Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia, Tel: +61 8 83137438, E-mail: azmeraw.amare{at}adelaide.edu.au
Posted April 03, 2024.
Pharmacogenomic Diversity in Psychiatry: Challenges and Opportunities in Africa
